वेक्यूरोनियम के इंटरैक्शन

हम जिन FDA लेबल और फैक्ट शीट को इंडेक्स करते हैं, उनमें वेक्यूरोनियम (न्यूरोमस्कुलर ब्लॉकर) के 71 इंटरैक्शन दर्ज हैं: 6 गंभीर, 41 मध्यम, 23 मामूली, और 1 ऐसे जिनमें लेबल बताता है कि कोई महत्वपूर्ण इंटरैक्शन नहीं है। नीचे की हर प्रविष्टि उस वाक्य को उद्धृत करती है जिस पर वह आधारित है। दवा का यह पेज एक शुरुआती बिंदु है, आपकी स्थिति के लिए कोई फ़ैसला नहीं।

लेबल से लिए गए इंटरैक्शन

गंभीर इंटरैक्शन (6)

  • क्विनीनमलेरिया-रोधी दवागंभीर

    Avoid concomitant use with neuromuscular blocking agents. (क्विनीन लेबल, चेतावनियां और सावधानियां)

  • नियोमाइसिनएमिनोग्लाइकोसाइडगंभीर

    The possibility of the occurrence of neuromuscular blockage and respiratory paralysis should be considered if neomycin is administered, especially to patients receiving anesthetics, neuromuscular blocking agents such as tubocurarine, succinylcholine, decamethonium, or in patients receiving massive transfusions of citrate anticoagulated blood. (नियोमाइसिन लेबल, बॉक्स्ड चेतावनी)

  • प्लाज़ोमाइसिनएमिनोग्लाइकोसाइडगंभीर

    During therapy with ZEMDRI, monitor for adverse reactions associated with neuromuscular blockade, particularly in high-risk patients, such as patients with underlying neuromuscular disorders (including myasthenia gravis) or in patients concomitantly receiving neuromuscular blocking agents [see Warning and Precautions (5.3) ] . (प्लाज़ोमाइसिन लेबल, बॉक्स्ड चेतावनी)

  • रेमिफेंटानिलओपिओइडगंभीर

    In the case of life-threatening muscle rigidity, a rapid onset neuromuscular blocker or naloxone may be administered. (रेमिफेंटानिल लेबल, चेतावनियां और सावधानियां)

  • रोक्यूरोनियमन्यूरोमस्कुलर ब्लॉकरगंभीर

    Rocuronium Bromide Injection is contraindicated in patients known to have hypersensitivity (e.g., anaphylaxis) to rocuronium bromide or other neuromuscular blocking agents [see Warnings and Precautions ( 5.2 )] . (रोक्यूरोनियम लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • Reversal of Neuromuscular Blocking Agents Other Than Rocuronium or Vecuronium Do not use BRIDION to reverse blockade induced by nonsteroidal neuromuscular blocking agents such as succinylcholine or benzylisoquinolinium compounds. (सुगैमाडेक्स लेबल, चेतावनियां और सावधानियां)

मध्यम इंटरैक्शन (41)

  • आइसोफ्लुरेनजनरल एनेस्थेटिकमध्यम

    Inhalational Anesthetics Use of volatile inhalational anesthetics such as enflurane, isoflurane, and halothane with vecuronium will enhance neuromuscular blockade. (वेक्यूरोनियम लेबल, सावधानियां)

  • इनकोबोटुलिनमटॉक्सिनAन्यूरोमस्कुलर ब्लॉकरमध्यम

    Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (वेक्यूरोनियम लेबल, चेतावनियां)

  • एटोमिडेटजनरल एनेस्थेटिकमध्यम

    Inhalational Anesthetics Use of volatile inhalational anesthetics such as enflurane, isoflurane, and halothane with vecuronium will enhance neuromuscular blockade. (वेक्यूरोनियम लेबल, सावधानियां)

  • एट्राक्यूरियमन्यूरोमस्कुलर ब्लॉकरमध्यम

    Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (वेक्यूरोनियम लेबल, चेतावनियां)

  • ऑर्फेनाड्रिनमसल रिलैक्सेंटमध्यम

    In such patients, a peripheral nerve stimulator and use of a small test dose may be of value in monitoring the response to administration of muscle relaxants. (वेक्यूरोनियम लेबल, चेतावनियां)

  • In such patients, a peripheral nerve stimulator and use of a small test dose may be of value in monitoring the response to administration of muscle relaxants. (वेक्यूरोनियम लेबल, चेतावनियां)

  • ओनाबोटुलिनमटॉक्सिनAन्यूरोमस्कुलर ब्लॉकरमध्यम

    Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (वेक्यूरोनियम लेबल, चेतावनियां)

  • केटामिनCNS डिप्रेसेंटमध्यम

    Inhalational Anesthetics Use of volatile inhalational anesthetics such as enflurane, isoflurane, and halothane with vecuronium will enhance neuromuscular blockade. (वेक्यूरोनियम लेबल, सावधानियां)

  • कैरिसोप्रोडोलमसल रिलैक्सेंटमध्यम

    In such patients, a peripheral nerve stimulator and use of a small test dose may be of value in monitoring the response to administration of muscle relaxants. (वेक्यूरोनियम लेबल, चेतावनियां)

  • क्लिंडामाइसिनएंटीबायोटिकमध्यम

    • Neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. (क्लिंडामाइसिन लेबल, दवाओं के इंटरैक्शन)

  • क्लोरज़ोक्साज़ोनमसल रिलैक्सेंटमध्यम

    In such patients, a peripheral nerve stimulator and use of a small test dose may be of value in monitoring the response to administration of muscle relaxants. (वेक्यूरोनियम लेबल, चेतावनियां)

  • क्विनिडिनएंटीएरिदमिकमध्यम

    Quinidine potentiates the actions of depolarizing (succinylcholine, decamethonium) and non-depolarizing ( d -tubocurarine, pancuronium) neuromuscular blocking agents . (क्विनिडिन लेबल, दवाओं के इंटरैक्शन)

  • टिज़ानिडिनमसल रिलैक्सेंटमध्यम

    In such patients, a peripheral nerve stimulator and use of a small test dose may be of value in monitoring the response to administration of muscle relaxants. (वेक्यूरोनियम लेबल, चेतावनियां)

  • डेफ्लाज़ाकॉर्टकॉर्टिकोस्टेरॉइडमध्यम

    Myopathy Patients receiving corticosteroids, including EMFLAZA, and concomitant therapy with neuromuscular blocking agents (e.g., pancuronium) or patients with disorders of neuromuscular transmission (e.g., myasthenia gravis) may be at increased risk of developing acute myopathy. (डेफ्लाज़ाकॉर्ट लेबल, चेतावनियां और सावधानियां)

  • डेसफ्लुरेनजनरल एनेस्थेटिकमध्यम

    Inhalational Anesthetics Use of volatile inhalational anesthetics such as enflurane, isoflurane, and halothane with vecuronium will enhance neuromuscular blockade. (वेक्यूरोनियम लेबल, सावधानियां)

  • डैंट्रोलीनमसल रिलैक्सेंटमध्यम

    In such patients, a peripheral nerve stimulator and use of a small test dose may be of value in monitoring the response to administration of muscle relaxants. (वेक्यूरोनियम लेबल, चेतावनियां)

  • पाइपेरासिलिन और टैज़ोबैक्टमपेनिसिलिन एंटीबायोटिकमध्यम

    Vecuronium Piperacillin when used concomitantly with vecuronium has been implicated in the prolongation of the neuromuscular blockade of vecuronium. (पाइपेरासिलिन और टैज़ोबैक्टम लेबल, दवाओं के इंटरैक्शन)

  • पाइरिडोस्टिग्मिनकोलिनेस्टेरेज़ इनहिबिटरमध्यम

    Depolarizing neuromuscular blocking agents: Increased effect. (पाइरिडोस्टिग्मिन लेबल, दवाओं के इंटरैक्शन)

  • प्रिमिडोनएंटीकन्वल्सेंट (दौरे की दवा)मध्यम

    Thiopental Reconstituted vecuronium, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions such as thiopental) in the same syringe or administered simultaneously during intravenous infusion through the same needle or through the same intravenous line (see DOSAGE AND ADMINISTRATION -COMPATIBILITY ). (वेक्यूरोनियम लेबल, सावधानियां)

  • प्रोकेनामाइडएंटीएरिदमिकमध्यम

    Patients taking PA who require neuromuscular blocking agents such as succinylcholine may require less than usual doses of the latter, due to PA effects on reducing acetylcholine release. (प्रोकेनामाइड लेबल, दवाओं के इंटरैक्शन)

  • प्रोपोफोलCNS डिप्रेसेंटमध्यम

    Inhalational Anesthetics Use of volatile inhalational anesthetics such as enflurane, isoflurane, and halothane with vecuronium will enhance neuromuscular blockade. (वेक्यूरोनियम लेबल, सावधानियां)

  • फेंटानिलओपिओइडमध्यम

    • Risks of Skeletal Muscle Rigidity and Skeletal Muscle Movement : Manage with neuromuscular blocking agent. (फेंटानिल लेबल, चेतावनियां और सावधानियां)

  • फेनोबार्बिटोनबार्बिट्यूरेटमध्यम

    Thiopental Reconstituted vecuronium, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions such as thiopental) in the same syringe or administered simultaneously during intravenous infusion through the same needle or through the same intravenous line (see DOSAGE AND ADMINISTRATION -COMPATIBILITY ). (वेक्यूरोनियम लेबल, सावधानियां)

  • Thiopental Reconstituted vecuronium, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions such as thiopental) in the same syringe or administered simultaneously during intravenous infusion through the same needle or through the same intravenous line (see DOSAGE AND ADMINISTRATION -COMPATIBILITY ). (वेक्यूरोनियम लेबल, सावधानियां)

  • बैक्लोफेनमसल रिलैक्सेंटमध्यम

    In such patients, a peripheral nerve stimulator and use of a small test dose may be of value in monitoring the response to administration of muscle relaxants. (वेक्यूरोनियम लेबल, चेतावनियां)

  • बोटुलिनम टॉक्सिन टाइप Aन्यूरोमस्कुलर ब्लॉकरमध्यम

    Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (वेक्यूरोनियम लेबल, चेतावनियां)

  • ब्यूटाल्बिटल और पैरासिटामोलबार्बिट्यूरेटमध्यम

    Thiopental Reconstituted vecuronium, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions such as thiopental) in the same syringe or administered simultaneously during intravenous infusion through the same needle or through the same intravenous line (see DOSAGE AND ADMINISTRATION -COMPATIBILITY ). (वेक्यूरोनियम लेबल, सावधानियां)

  • Thiopental Reconstituted vecuronium, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions such as thiopental) in the same syringe or administered simultaneously during intravenous infusion through the same needle or through the same intravenous line (see DOSAGE AND ADMINISTRATION -COMPATIBILITY ). (वेक्यूरोनियम लेबल, सावधानियां)

  • Thiopental Reconstituted vecuronium, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions such as thiopental) in the same syringe or administered simultaneously during intravenous infusion through the same needle or through the same intravenous line (see DOSAGE AND ADMINISTRATION -COMPATIBILITY ). (वेक्यूरोनियम लेबल, सावधानियां)

  • Thiopental Reconstituted vecuronium, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions such as thiopental) in the same syringe or administered simultaneously during intravenous infusion through the same needle or through the same intravenous line (see DOSAGE AND ADMINISTRATION -COMPATIBILITY ). (वेक्यूरोनियम लेबल, सावधानियां)

  • Thiopental Reconstituted vecuronium, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions such as thiopental) in the same syringe or administered simultaneously during intravenous infusion through the same needle or through the same intravenous line (see DOSAGE AND ADMINISTRATION -COMPATIBILITY ). (वेक्यूरोनियम लेबल, सावधानियां)

  • मेटाक्सालोनमसल रिलैक्सेंटमध्यम

    In such patients, a peripheral nerve stimulator and use of a small test dose may be of value in monitoring the response to administration of muscle relaxants. (वेक्यूरोनियम लेबल, चेतावनियां)

  • मेथोकार्बामोलमसल रिलैक्सेंटमध्यम

    In such patients, a peripheral nerve stimulator and use of a small test dose may be of value in monitoring the response to administration of muscle relaxants. (वेक्यूरोनियम लेबल, चेतावनियां)

  • मेथोहेक्सिटलबार्बिट्यूरेटमध्यम

    Inhalational Anesthetics Use of volatile inhalational anesthetics such as enflurane, isoflurane, and halothane with vecuronium will enhance neuromuscular blockade. (वेक्यूरोनियम लेबल, सावधानियां)

  • लिथियमसेरोटोनर्जिक दवामध्यम

    Neuromuscular Blocking Agents Clinical Impact: Lithium may prolong the effects of neuromuscular blocking agents. (लिथियम लेबल, दवाओं के इंटरैक्शन)

  • लिनकोमाइसिनएंटीबायोटिकमध्यम

    Drug Interactions Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; therefore, it should be used with caution in patients receiving such agents. (लिनकोमाइसिन लेबल, दवाओं के इंटरैक्शन)

  • वेरापामिलकैल्शियम चैनल ब्लॉकरमध्यम

    Neuromuscular Blocking Agents Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing). (वेरापामिल लेबल, दवाओं के इंटरैक्शन)

  • सक्सिनिलकोलिनन्यूरोमस्कुलर ब्लॉकरमध्यम

    Drug Interactions Prior administration of succinylcholine may enhance the neuromuscular blocking effect of vecuronium and its duration of action. (वेक्यूरोनियम लेबल, दवाओं के इंटरैक्शन)

  • साइक्लोबेंज़ाप्रिनमसल रिलैक्सेंटमध्यम

    In such patients, a peripheral nerve stimulator and use of a small test dose may be of value in monitoring the response to administration of muscle relaxants. (वेक्यूरोनियम लेबल, चेतावनियां)

  • सिसएट्राक्यूरियमन्यूरोमस्कुलर ब्लॉकरमध्यम

    Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (वेक्यूरोनियम लेबल, चेतावनियां)

  • सेवोफ्लुरेनजनरल एनेस्थेटिकमध्यम

    Inhalational Anesthetics Use of volatile inhalational anesthetics such as enflurane, isoflurane, and halothane with vecuronium will enhance neuromuscular blockade. (वेक्यूरोनियम लेबल, सावधानियां)

मामूली ज़िक्र (23)

  • एमिकासिनएमिनोग्लाइकोसाइडमामूली

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • कार्बामाज़ेपिनएंटीकन्वल्सेंट (दौरे की दवा)मामूली

    N e uromuscular Blocking Agents Resistance to the neuromuscular blocking action of the nondepolarizing neuromuscular blocking agents pancuronium, vecuronium, rocuronium and cisatracurium has occurred in patients chronically administered carbamazepine. (कार्बामाज़ेपिन लेबल, दवाओं के इंटरैक्शन)

  • कोलिस्टिमेथेटएंटीबायोटिकमामूली

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • गैलेंटामिनकोलिनेस्टेरेज़ इनहिबिटरमामूली

    Anesthesia Galantamine, as a cholinesterase inhibitor, is likely to exaggerate the neuromuscular blocking effects of succinylcholine-type and similar neuromuscular blocking agents during anesthesia. (गैलेंटामिन लेबल, चेतावनियां और सावधानियां)

  • जेंटामाइसिनएमिनोग्लाइकोसाइडमामूली

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • टाइजेसाइक्लिनटेट्रासाइक्लिन एंटीबायोटिकमामूली

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • टेट्रासाइक्लिनटेट्रासाइक्लिन एंटीबायोटिकमामूली

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • टोब्रामाइसिनएमिनोग्लाइकोसाइडमामूली

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • डिगॉक्सिनडिजिटेलिस ग्लाइकोसाइडमामूली

    Norepinephrine Dopamine Neuromuscular Blocking Agents Succinylcholine May cause sudden extrusion of potassium from muscle cells causing arrhythmias in patients taking digoxin. (डिगॉक्सिन लेबल, दवाओं के इंटरैक्शन)

  • डेक्सट्रोमेथॉर्फन और क्विनिडिनसेरोटोनर्जिक दवामामूली

    Other Experience concerning injection of quinidine during recovery from use of other muscle relaxants suggests that recurrent paralysis may occur. (वेक्यूरोनियम लेबल, सावधानियां)

  • डेमेक्लोसाइक्लिनटेट्रासाइक्लिन एंटीबायोटिकमामूली

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • In patients who have received neuromuscular blocking agents, doxapram may temporarily mask the residual effects of these drugs. (डॉक्साप्राम लेबल, दवाओं के इंटरैक्शन)

  • डॉक्सीसाइक्लिनटेट्रासाइक्लिन एंटीबायोटिकमामूली

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • डोनेपेज़िलकोलिनेस्टेरेज़ इनहिबिटरमामूली

    A synergistic effect may be expected with concomitant administration of succinylcholine, similar neuromuscular blocking agents, or cholinergic agonists ( 7.2 ) (डोनेपेज़िल लेबल, दवाओं के इंटरैक्शन)

  • पॉलीमिक्सिन Bएंटीबायोटिकमामूली

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • फेनिटोइनएंटीकन्वल्सेंट (दौरे की दवा)मामूली

    Neuromuscular blocking agents Cisatracurium, pancuronium, rocuronium and vecuronium: resistance to the neuromuscular blocking action of the nondepolarizing neuromuscular blocking agents has occurred in patients chronically administered phenytoin. (फेनिटोइन लेबल, दवाओं के इंटरैक्शन)

  • फॉस्फेनिटोइनएंटीकन्वल्सेंट (दौरे की दवा)मामूली

    Neuromuscular blocking agents Cisatracurium, pancuronium, rocuronium and vecuronium: resistance to the neuromuscular blocking action of the nondepolarizing neuromuscular blocking agents has occurred in patients chronically administered phenytoin. (फॉस्फेनिटोइन लेबल, दवाओं के इंटरैक्शन)

  • The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • बैसिट्रैसिनएंटीबायोटिकमामूली

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • मिनोसाइक्लिनटेट्रासाइक्लिन एंटीबायोटिकमामूली

    The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (वेक्यूरोनियम लेबल, सावधानियां)

  • मेमेंटिन और डोनेपेज़िलकोलिनेस्टेरेज़ इनहिबिटरमामूली

    Concomitant administration of succinylcholine, similar neuromuscular blocking agents, or cholinergic agonists may lead to synergistic effect. (मेमेंटिन और डोनेपेज़िल लेबल, दवाओं के इंटरैक्शन)

  • मैग्नीशियमविटामिन और मिनरलमामूली

    Magnesium salts, administered for the management of toxemia of (वेक्यूरोनियम लेबल, सावधानियां)

कोई महत्वपूर्ण इंटरैक्शन नहीं बताया गया (1)

  • डेक्समेडेटोमिडिनअल्फा-एड्रीनर्जिक एगोनिस्टकोई इंटरैक्शन नहीं

    Neuromuscular Blockers In one study of 10 healthy adult volunteers, administration of PRECEDEX for 45 minutes at a plasma concentration of one ng/mL resulted in no clinically meaningful increases in the magnitude of neuromuscular blockade associated with rocuronium administration. (डेक्समेडेटोमिडिन लेबल, दवाओं के इंटरैक्शन)

आप जो कुछ भी लेते हैं, उस सबके साथ वेक्यूरोनियम को जांचें। अपनी पूरी सूची जोड़ें; हर जोड़ी एक साथ जांची जाती है।

चेकर में खोलें

यह चिकित्सकीय सलाह नहीं है। गंभीरता लेबल के शब्दों को दर्शाती है, आपकी परिस्थितियों को नहीं। “गंभीर” चिह्न वाला संयोजन डॉक्टर की देखरेख में सामान्य बात हो सकता है, और “मामूली” चिह्न वाला संयोजन ऊंची खुराक पर मायने रख सकता है। फार्मासिस्ट से पूछें।